The thylacine, also known as the Tasmanian tiger, is the second undertaking by Colossal, a Texas-based biotechnology “de-extinction” company that last year announced it planned to use genetic engineering techniques to recreate the woolly mammoth and return it to the Arctic tundra.

Its new project is a partnership with the University of Melbourne, which earlier this year received a $5m philanthropic gift to open a thylacine genetic restoration lab. The lab’s team has previously sequenced the genome of a juvenile specimen held by Museums Victoria, providing what its leader, Prof Andrew Pask, called “a complete blueprint on how to essentially build a thylacine”.

The thylacine was Australia’s only marsupial apex predator. It once lived across the continent, but was restricted to Tasmania about 3,000 years ago. Dog-like in appearance and with stripes across its back, it was extensively hunted after European colonisation. The last known survivor died in captivity in 1936. Despite many reported sightings in the decades that followed, and some quixotic attempts to prove its ongoing existence, it was officially declared extinct in the 1980s.